Publication

Video

Supplements and Featured Publications

Advances in Immunotherapy in Metastatic Non–Small Cell Lung Cancer
Volume1
Issue 1

Dr. Goldberg on the Evolving Role of Immunotherapy in NSCLC

Sarah B. Goldberg, MD, MPH, discusses the evolving role of immunotherapy in non–small cell lung cancer.

Sarah B. Goldberg, MD, MPH, an associate professor of Internal Medicine and the associate director of the Hematology/Oncology Fellowship Program at the Yale School of Medicine, discusses the evolving role of immunotherapy in non–small cell lung cancer (NSCLC).

Immunotherapy continues to play a bigger role within NSCLC, as more clinical studies underscore the efficacy of this approach, says Goldberg. A few years ago, immunotherapy was largely used in the second-line setting for patients with advanced or metastatic disease, but it has since moved up into the frontline setting for patients with NSCLC and small cell lung cancer, adds Goldberg.

Moreover, it is becoming clear that combination regimens may provide added benefit to patients, says Goldberg. PD-L1 expression on tumor cells can be used to help guide selection and inform whether a single-agent approach or a combination regimen should be administered. Immunotherapy has also emerged as a strategy for patients with stage III lung cancer, with clinical trials showing benefit with this modality in this population, as well, Goldberg concludes.

Related Videos
Dr Cascone on Evaluating Neoadjuvant Durvalumab-Based Regimens in Resectable NSCLC
FRCSI, FRCSEd, medical director, Thoracic Cancer Program, and associate executive director, AdventHealth Cancer Institute
Benjamin P. Levy, MD, clinical director, Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital; and associate professor, oncology, Johns Hopkins University School of Medicine
Russell Hales, MD, director, Thoracic Oncology Multidisciplinary Program, associate professor, clinical radiation oncology and molecular radiation sciences, and director, thoracic multidisciplinary clinic, John Hopkins University School of Medicine
Estelamari Rodriguez, MD, MPH, associate director, Community Outreach – Thoracic Oncology, Sylvester Comprehensive Cancer Center
Misty D. Shields, MD, PhD, assistant professor, clinical medicine, Department of Medicine, Division of Hematology/Oncology, Indiana University (IU) School of Medicine; and associate member, Experimental and Developmental Therapeutics, IU Melvin and Bren Simon Comprehensive Cancer Center
Corey J. Langer, MD, director, Thoracic Oncology, Penn Medicine; and professor, medicine (hematology-oncology), the Hospital of the University of Pennsylvania, Perelman School of Medicine
Alexander I. Spira MD, PhD, FACP, FASCO
Hidehito Horinouchi, MD, PhD